{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:54:24Z","timestamp":1793066064325,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303246"],"award-info":[{"award-number":["82303246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ50493"],"award-info":[{"award-number":["2025JJ50493"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ50543"],"award-info":[{"award-number":["2025JJ50543"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.drup.2026.101413","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:33:51Z","timestamp":1778196831000},"page":"101413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["ENO1 lactylation drives bevacizumab resistance through metabolic reprogramming and angiogenesis in ovarian cancer"],"prefix":"10.1016","volume":"87","author":[{"given":"Tian","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongjin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drup.2026.101413_bib1","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1074\/jbc.272.3.1709","article-title":"Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein","volume":"272","author":"Austen","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13046-023-02779-x","article-title":"Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts","volume":"42","author":"Boso","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.drup.2026.101413_bib3","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.drup.2026.101413_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1515\/mr-2024-0091","article-title":"Histone lactylation as a driver of metabolic reprogramming and immune evasion","volume":"5","author":"Cai","year":"2025","journal-title":"Med. Rev."},{"key":"10.1016\/j.drup.2026.101413_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"8021","key":"10.1016\/j.drup.2026.101413_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.drup.2026.101413_bib7","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.7150\/thno.73223","article-title":"Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.drup.2026.101413_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121601","article-title":"Rewiring of lipid metabolism and storage in ovarian cancer cells after anti-VEGF therapy","volume":"8","author":"Curtarello","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.drup.2026.101413_bib9","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.32604\/or.2025.068292","article-title":"Isoliquiritigenin inhibits triple-negative breast cancer progression via targeting the IRF5\/SLC7A5\/IDO1-mediated tryptophan metabolism pathway","volume":"33","author":"Duan","year":"2025","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-025-07571-7","article-title":"IGF2BP3\/ESM1\/KLF10\/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming","volume":"16","author":"Gao","year":"2025","journal-title":"Cell Death & Dis."},{"issue":"2","key":"10.1016\/j.drup.2026.101413_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106020","article-title":"Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer","volume":"26","author":"Glassman","year":"2023","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.drup.2026.101413_bib12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41416-025-03182-3","article-title":"ENO1 promotes cancer metastasis via stimulating metabolism reprogramming in osteosarcoma","volume":"133","author":"Huang","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"33","key":"10.1016\/j.drup.2026.101413_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202506529","article-title":"WTAP mediated m6A modification stabilizes PDIA3P1 and promotes tumor progression driven by histone lactylation in esophageal squamous cell carcinoma","volume":"12","author":"Huang","year":"2025","journal-title":"Adv. Sci."},{"issue":"18","key":"10.1016\/j.drup.2026.101413_bib14","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1158\/0008-5472.CAN-10-2719","article-title":"Biological roles of the delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer","volume":"71","author":"Hu","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2026.101413_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108506","article-title":"Therapeutic targeting of the pituitary tumor microenvironment","volume":"250","author":"Ilie","year":"2023","journal-title":"Pharm. Ther."},{"issue":"9","key":"10.1016\/j.drup.2026.101413_bib16","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.bbamcr.2014.04.023","article-title":"Smurf2 regulates the degradation of YY1","volume":"1843","author":"Jeong","year":"2014","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trecan.2016.11.007","article-title":"Angiogenesis and metabolism: entwined for therapy resistance","volume":"3","author":"Jim\u00e9nez-Valerio","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2026.101413_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139072","article-title":"Tanshinone I reprograms glycolysis metabolism to regulate histone H3 lysine 18 lactylation (H3K18la) and inhibits cancer cell growth in ovarian cancer","volume":"291","author":"Jin","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.drup.2026.101413_bib19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/nar\/25.4.843","article-title":"Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1","volume":"25","author":"Kalenik","year":"1997","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13148-022-01326-3","article-title":"CRNDE acts as an epigenetic modulator of the p300\/YY1 complex to promote HCC progression and therapeutic resistance","volume":"14","author":"Liu","year":"2022","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12672-025-02113-1","article-title":"ESM1 suppresses LncRNA GAS5\/miR-23a-3p\/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K\/AKT pathway","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12967-023-04819-8","article-title":"ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2\/STAT3 pathway and interacting with ESM1","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1186\/s12967-024-05847-8","article-title":"Role of ENO1 and its targeted therapy in tumors","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drup.2026.101413_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218227","article-title":"Histone lactylation bridges metabolic reprogramming with chromatin-immune crosstalk in triple-negative breast cancer","volume":"639","author":"Li","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2026.101413_bib26","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.cmet.2024.07.011","article-title":"Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7150\/ijbs.66839","article-title":"Validation of ESM1 related to ovarian cancer and the biological function and prognostic significance","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","article-title":"Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101413_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102945","article-title":"Optimal bevacizumab treatment strategy in advanced ovarian cancer: a review","volume":"137","author":"Monk","year":"2025","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10.1016\/j.drup.2026.101413_bib30","doi-asserted-by":"crossref","first-page":"x53","DOI":"10.1093\/annonc\/mdt472","article-title":"Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease","volume":"24","author":"Monk","year":"2013","journal-title":"Ann. Oncol."},{"issue":"Pt 3","key":"10.1016\/j.drup.2026.101413_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1242\/jcs.00870","article-title":"The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase","volume":"117","author":"Palko","year":"2004","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.drup.2026.101413_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"issue":"43","key":"10.1016\/j.drup.2026.101413_bib33","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1038\/onc.2008.181","article-title":"p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc","volume":"27","author":"Sankar","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41392-025-02451-0","article-title":"Alpha-enolase influences ATP pool of cytoplasm and lactate homeostasis by regulating glycolysis in gastric cancer","volume":"10","author":"Shu","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.drup.2026.101413_bib35","article-title":"Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer","volume":"13","author":"Song","year":"2023","journal-title":"Front Oncol."},{"issue":"7","key":"10.1016\/j.drup.2026.101413_bib36","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.7150\/thno.104858","article-title":"Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation","volume":"15","author":"Sun","year":"2025","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.drup.2026.101413_bib37","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41589-023-01391-6","article-title":"ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism","volume":"19","author":"Sun","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-018-08225-3","article-title":"The p300\/YY1\/miR-500a-5p\/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/1078-0432.CCR-23-0771","article-title":"Analysis of tumor microenvironment changes after neoadjuvant chemotherapy with or without bevacizumab in advanced ovarian cancer (GEICO-89T\/MINOVA Study)","volume":"30","author":"Tavira","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101413_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.592164","article-title":"The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1","volume":"8","author":"Verheul","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.drup.2026.101413_bib41","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s42255-023-00883-y","article-title":"ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy","volume":"5","author":"Wang","year":"2023","journal-title":"Nat. Metab."},{"issue":"12","key":"10.1016\/j.drup.2026.101413_bib42","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/bph.16332","article-title":"Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification","volume":"181","author":"Wang","year":"2024","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.drup.2026.101413_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154940","article-title":"Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites","volume":"118","author":"Xu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drup.2026.101413_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101274","article-title":"ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion","volume":"82","author":"Yang","year":"2025","journal-title":"Drug Resist Updat"},{"issue":"9","key":"10.1016\/j.drup.2026.101413_bib45","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1073\/pnas.1916198117","article-title":"Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","article-title":"ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1","volume":"3","author":"Zhang","year":"2022","journal-title":"Nat. Cancer"},{"issue":"7779","key":"10.1016\/j.drup.2026.101413_bib48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.drup.2026.101413_bib49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41419-025-08023-y","article-title":"Lactate-mediated histone lactylation promotes melanoma angiogenesis via IL-33\/ST2 axis","volume":"16","author":"Zhao","year":"2025","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.drup.2026.101413_bib50","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:35:25Z","timestamp":1783103725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"alternative-id":["S1368764626000646"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101413","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ENO1 lactylation drives bevacizumab resistance through metabolic reprogramming and angiogenesis in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101413"}}